Drug Approval | March 27, 2023
Briefs: Morepen Laboratories and Zydus Lifesciences
The company is addressing these observations
The company is addressing these observations
The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Mindset disagrees with and denies the allegations set forth from Reunion.
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Marksans' OTC Famotidine Tablets USP are acid reducers
Subscribe To Our Newsletter & Stay Updated
